Integra LifeSciences Reports Third Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St set for higher open as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Integra LifeSciences (IART) PT Raised to $52 at Truist Securities
October 26, 2022 4:54 PM EDTTruist Securities analyst Richard Newitter raised the price target on Integra LifeSciences (NASDAQ: IART) to $52.00 (from $46.00) while maintaining a Hold rating.
The analyst commented, "We still see IART in transition to its LT rev growth and margin goals, but IART's 3Q... More
